ImmuPharma PLC | |
Stock Exchange | London Stock Exchange |
EPS |
GBP0.05 |
Market Cap |
GBP14.71 M |
Shares Outstanding |
139.47 M |
Public Float |
102.98 M |
Address |
50 Broadway London Greater London SW1 H0RG United Kingdom |
Employees | - |
Website | http://www.immupharma.com |
Updated | 07/08/2019 |
ImmuPharma Plc engages in the research, development, and commercialisation of pharmaceutical products. Its drug candidate, Lupuzor, is a potential treatment for the autoimmune chronic inflammatory disease lupus. The company was founded by Richard Warr and Dimitri F. |